Early Notice on CER Funding
The Agency for Healthcare Research and Quality will publish grant and contract solicitations for comparative effectiveness research in the fall, according to a notice in today’s Federal Register. AHRQ has $300 million appropriated through the American Recovery and Reinvestment Act to support of such research.
The ARRA funding will focus initially on 14 priority conditions established by Health and Human Services under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, according to the notice.
Since 2005 AHRQ has focused its CER efforts through the Effective Health Care Program, which was authorized under the Medicare Prescription Drug, Improvement, and Modernization Act. The program provides “systematic reviews and develops other translational information and tools designed to inform health care decision making,” according to AHRQ, and “advances the methodology of [CER] and provides training grants to enhance the pool of researchers who can perform CER.”
Funding will begin in spring 2010. The solicitations will be published in the NIH Guide for Grants and Contracts.